iStent may be effective in severe primary open-angle glaucoma

Patients with severe primary open-angle glaucoma who received a trabecular microbypass stent during cataract surgery experienced a significant drop in IOP and medication use.
The retrospective case series included 59 eyes with severe primary open-angle glaucoma that underwent cataract surgery and received one iStent (Glaukos). After surgery, patients were prescribed a daily NSAID for 4 weeks, moxifloxacin 0.05% for 1 week and steroid drops for 4 weeks.
At baseline, mean IOP was 19.25 mm Hg, and at 1 year, mean IOP was 14.38 mm Hg (P < .01). At 24 (Read more...)

Full Story →